GENE ONLINE|News &
Opinion
Blog

BeiGene
Cell Therapy as a Pillar of Future Therapeutics, an Interview with Alex Huang, Vice President and Head of Cell Therapy at BeiGene
2022-10-05
BeiGene Granted NMPA Approval to Treat World’s Most Prevalent Esophageal Cancer
2022-04-20
EMA Begins Review of BeiGene, Novartis’s PD-1 Antibody for Esophageal and Lung Cancer
2022-04-13
Biotech Showcase 2022: The China Factor
2022-01-24
Novartis Licenses BeiGene’s Antibody for a Potential $2.8 Billion After Its Own Drug Disappoints
2021-12-21
BeiGene launches IPO on Shanghai’s STAR market to raise $3B
2021-12-03
Brukinsa Receives EU Approval for the Treatment of Rare Lymphoma
2021-11-27
San Diego Startup Nabs $140 Million Following BeiGene, Kite Partnerships
2021-11-03
BeiGene Gets Its First Regulatory Nod in Australia for Rare Lymphoma
2021-10-08
FDA Accepts BeiGene’s BLA for Esophageal Cancer Drug
2021-09-14
BeiGene’s Brukinsa Bags Second FDA Approval, to Rival Imbruvica in Treating a Rare Cancer
2021-09-06
Chinese Regulator Accepts BeiGene’s Tislelizumab sBLA for Nasopharyngeal Cancer
2021-08-23
China’s BeiGene to Build a Biologics Manufacturing Site in the US
2021-08-04
BITT’s TNFR2 Antagonist to Enter Clinical Trials In Collaboration with BeiGene
2021-02-20
BeiGene’s Immunotherapy Drug Shines in Phase ESCC Trial
2021-01-31
1 2
LATEST
Rebyota Passes Through FDA To Become First Approved Fecal Microbiota Product
2022-12-05
RemeGen Presented New Data Updates on Telitacicept for SLE and primary Sjogren’s syndrome at ACR Convergence 2022
2022-12-05
EMA Urges Pholcodine’s Removal from European Market Following Safety Study
2022-12-05
Lynk Pharmaceuticals Announces First Patient Dosed in Phase Ⅱ Clinical Study of LNK01003 in Patients with Ulcerative Colitis
2022-12-04
Cure Brain Cancer Foundation Rings Nasdaq Opening Bell, Announces U.S. Expansion
2022-12-02
Focus-X Therapeutics, a Viva Biotech Portfolio Company, Successfully Reached an Acquisition Agreement with Full-Life Technologies
2022-12-02
Pfizer To Invest $1.26 Billion In Irish Plant, Forms New Vant Company Targeting Inflammation
2022-12-02
EVENT
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, USA
2022-12-14
BIOHK2022
Hong Kong, China
2022-12-21
Avatar Medicine Forum
Online
2023-01-07
7th Asia Microbiome Conference
Taipei, Taiwan
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!